Secondary Logo

Journal Logo

H-105 Reflections on the impact of nucleotide antiviral drugs

Martin, John, PhD

JAIDS Journal of Acquired Immune Deficiency Syndromes: April 2018 - Volume 77 - Issue - p 47
doi: 10.1097/01.qai.0000532626.00464.29
Abstracts: PDF Only

Antiviral nucleotide prodrugs have benefitted patients suffering from HIV and viral hepatitis, providing for the possibility to live longer, healthier lives. In addition, tenofovir has allowed for pre-exposure prophylaxis to prevent HIV infection. This is an example of the pioneering work of Salim and Quarraisha Karim.

Gilead Sciences

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.